XML 17 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 190,943,000 $ 306,235,000
Marketable securities 731,833,000 212,613,000
Prepaid expenses and other current assets 21,919,000 6,227,000
Total current assets 944,695,000 525,075,000
Property and equipment, net 5,643,000 4,013,000
Restricted cash 2,367,000 849,000
Total assets 952,705,000 529,937,000
Current liabilities:    
Accounts payable 34,036,000 9,350,000
Accrued expenses 51,994,000 42,601,000
Total current liabilities 86,030,000 51,951,000
Other liabilities 3,704,000 2,511,000
Total liabilities 89,734,000 54,462,000
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized at December 31, 2018 and 2017; no shares issued or outstanding at December 31, 2018 and 2017
Common stock, $0.0001 par value per share; 120,000,000 shares authorized at December 31, 2018 and 2017; 46,891,296 and 42,003,894 shares issued at December 31, 2018 and 2017, respectively; 46,888,263 and 42,002,934 shares outstanding at December 31, 2018 and 2017, respectively 5,000 5,000
Treasury stock, at cost, 3,033 and 960 shares at December 31, 2018 and December 31, 2017, respectively (211,000) (113,000)
Additional paid-in capital 1,827,021,000 1,066,059,000
Accumulated deficit (963,329,000) (590,447,000)
Accumulated other comprehensive loss (515,000) (29,000)
Total stockholders’ equity 862,971,000 475,475,000
Total liabilities and stockholders’ equity $ 952,705,000 $ 529,937,000